Pharmacogenomics and Personalized Medicines  
Click on the session title for a complete description.
Day Session Link
Monday Pharmacogenomics in Action: A Practical View of Pharmacogenomic Submissions, FDA Review Process, and Label Revisions
Tuesday Pharmacoeconomics, Cost Effectiveness, and Outcome Analysis for Personalized Medicine
Tuesday Biomarkers for Drug Safety and Development: Perspectives from the Institute of Medicine and Industry
Wednesday New Approaches to Toxicity Testing to Support Pharmaceutical Development - Part 2 of 2:  New Models
Wednesday New Approaches to Toxicity Testing to Support Pharmaceutical Development - Part 1 of 2: New Endpoints
Wednesday Potentially Genotoxic Impurities, Metabolites and Degradates: The Need for an Integrated Approach to Safety Assessment
Wednesday New Drug Information Databases at the National Library of Medicine
Wednesday Challenges in Developing and Commercializing Personalized Healthcare Products
Wednesday Personalized Medicine: 2009 Update
Thursday Updating ICH S6 Guidance on Preclinical Safety Evaluation of Biotechnology-derived Pharmaceuticals
© 2011 DIA | Home | diahome.org | Site Map | Contact Us | Disclaimer | Privacy Policy